TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29390278

Group type: EXPERIMENTAL
Intervention: Educational activities in the classroom
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Changes in the school environment (nudge strategies)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Educational activities and changes in the school environment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (without any activity)
Number of subjects: 18
Study: 25948166

Group type: EXPERIMENTAL
Intervention: OSTAP block with 20 ml 0.25% bupivacaine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (paracetamol, tenoxicam, and tramadol as required)
Number of subjects: 76
Study: 23541971

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Control group (no CRT)
Number of subjects: 813
Study: 20519697

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day(-1) orally for 4 weeks)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg day(-1) orally for 4 weeks)
Number of subjects: 379
Study: 19333536

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 16677152

Group type: EXPERIMENTAL
Intervention: Dynamic (99m)Tc-HIDA SPECT
Number of subjects: 18
Study: 15186687

Group type: EXPERIMENTAL
Intervention: Minimal risk procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical measures
Number of subjects: 0
Study: 11590500

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 (1.2 million IU/m2 once daily) in conjunction with HAART
Number of subjects: 115

Group type: COMPARATOR
Intervention: HAART alone (control group)
Number of subjects: 115
Study: 9547441

Group type: EXPERIMENTAL
Intervention: Nebivolol 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nebivolol 5.0 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8147960

Group type: EXPERIMENTAL
Intervention: Intensified insulin treatment
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard insulin treatment
Number of subjects: 102
Study: 2897299

Group type: EXPERIMENTAL
Intervention: Propranolol (240 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atenolol (200 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bisoprolol (100 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30883331

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dry needling
Number of subjects: 42
Study: 29976553

Group type: EXPERIMENTAL
Intervention: Exercise plus beetroot juice (4.2 mmol concentrated beetroot juice)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercise plus placebo
Number of subjects: 24
Study: 26707134

Group type: EXPERIMENTAL
Intervention: 0.25 μg/day calcitriol (n=48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (n=50)
Number of subjects: 98
Study: 25111032

Group type: EXPERIMENTAL
Intervention: Auditory-based cognitive training for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up testing 6 months after training
Number of subjects: 0
Study: 22261439

Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (B6, B12, folic acid) for 6 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic and strength training) for 6 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of B vitamin supplementation and exercise training for 6 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 20437565

Group type: EXPERIMENTAL
Intervention: Gabapentin (1,200mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Memantine (40 mg/day)
Number of subjects: 10
Study: 17510229

Group type: EXPERIMENTAL
Intervention: Static stretching of quadriceps
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Static stretching of hamstring
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Static stretching of adductors
Number of subjects: 39
Study: 16079656

Group type: EXPERIMENTAL
Intervention: Single-layer closure with simple interrupted 6-0 polypropylene sutures
Number of subjects: 65

Group type: COMPARATOR
Intervention: Double-layer closure with simple interrupted 6-0 polypropylene plus inverted deep dermal 5-0 polyglactin sutures
Number of subjects: 65
Study: 12385921

Group type: EXPERIMENTAL
Intervention: Saw palmetto herbal blend (SPHB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10630348

Group type: EXPERIMENTAL
Intervention: Neural therapy (injection of local anesthetic without adrenaline into specific trigger points)
Number of subjects: 61
Study: 8520623

Group type: EXPERIMENTAL
Intervention: Norethindrone (low-dose therapy)
Number of subjects: 0
Study: 2239806

Group type: EXPERIMENTAL
Intervention: Mitoxantrone 12 mg/m2 daily for 3 days plus etoposide 100 mg/m2 daily by constant infusion for 5 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mitoxantrone 12 mg/m2 daily for 3 days plus etoposide 150 mg/m2 daily by constant infusion for 5 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mitoxantrone 12 mg/m2 daily for 3 days plus etoposide 200 mg/m2 daily by constant infusion for 5 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mitoxantrone plus etoposide (various doses)
Number of subjects: 32
Study: 374202

Group type: EXPERIMENTAL
Intervention: etamsylate
Number of subjects: 107

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 107
Study: 29962254

Group type: EXPERIMENTAL
Intervention: Soluble mate tea (SMT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 9
Study: 28303900

Group type: EXPERIMENTAL
Intervention: Amphetamine (20 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: fMRI assessment during inhibition task
Number of subjects: 63
Study: 26235968

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg/day) for 6 months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (25 mg daily) for 6 months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of vitamin E and clomiphene citrate for 6 months
Number of subjects: 90
Study: 23518604

Group type: EXPERIMENTAL
Intervention: Exercise program (12-week course)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low intensity exercise group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High intensity exercise group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise intensity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise intensity (after adjustment for confounders)
Number of subjects: 0
Study: 21877679

Group type: EXPERIMENTAL
Intervention: ReSTOR +3.00-D add IOL
Number of subjects: 40

Group type: COMPARATOR
Intervention: ReSTOR +4.00-D add IOL
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 19728188

Group type: EXPERIMENTAL
Intervention: Hydrocodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing method
Number of subjects: 0
Study: 16899099

Group type: EXPERIMENTAL
Intervention: 0.2% CHX mouthrinse
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.2% CHX/0.055% sodium fluoride mouthrinse
Number of subjects: 90

Group type: COMPARATOR
Intervention: Positive control (CHX mouthrinse)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Negative control (placebo)
Number of subjects: 90
Study: 15313956

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 12562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12562
Study: 11558245

Group type: EXPERIMENTAL
Intervention: Routine medical testing (12-lead electrocardiogram, complete blood count, serum glucose measurements)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Selective medical testing (no routine tests unless new or worsening medical problems)
Number of subjects: 1025
Study: 9756146

Group type: EXPERIMENTAL
Intervention: Intranasal apomorphine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 9
Study: 7834052

Group type: EXPERIMENTAL
Intervention: Extracorporeal blood circulation and oxygenation during bypass surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reperfusion of the myocardium following removal of the aortic cross clamp
Number of subjects: 0
Study: 3139285

Group type: EXPERIMENTAL
Intervention: 5-day rIL-2 bolus (10^5 units/kg every 8 hours) followed by LAK cell infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 3-day rIL-2 prime and 6-day continuous infusion rIL-2 (3 x 10^6 units/m2/day) with LAK cell infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LAK cell infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: In vitro LAK generation cultures
Number of subjects: 15
Study: 29532729

Group type: EXPERIMENTAL
Intervention: Endolymphatic sac shunt insertion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ventilating tube insertion in tympanic membrane
Number of subjects: 29
Study: 26910333

Group type: EXPERIMENTAL
Intervention: B-type natriuretic peptide (BNP)
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (hs-cTnI)
Number of subjects: 1131
Study: 26195509

Group type: EXPERIMENTAL
Intervention: Faldaprevir plus pegylated interferon alpha/ribavirin (PR)
Number of subjects: 3124

Group type: COMPARATOR
Intervention: Placebo plus pegylated interferon alpha/ribavirin (PR)
Number of subjects: 3124
Study: 23464951

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) and unsupervised at-home range of motion exercises
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional physical therapy with a licensed therapist
Number of subjects: 70
Study: 21439528

Group type: EXPERIMENTAL
Intervention: Very-low-dose heparin (2,000 IU)
Number of subjects: 465

Group type: COMPARATOR
Intervention: Low-dose heparin (5,000 IU)
Number of subjects: 465
Study: 18192671

Group type: EXPERIMENTAL
Intervention: GnRH agonist (0.1 mg triptorelin) administered 6 days after ICSI
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo administered 6 days after ICSI
Number of subjects: 570
Study: 16611715

Group type: EXPERIMENTAL
Intervention: Dipstick proteinuria 1+
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Dipstick proteinuria >=2+
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: eGFR <60 ml/min per 1.73 m²
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: eGFR <60 ml/min per 1.73 m² and >=2+ proteinuria
Number of subjects: 12866
Study: 14606990

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 0
Study: 10960754

Group type: EXPERIMENTAL
Intervention: Hydrostatic pressure of 15cm H(2)O
Number of subjects: 30

Group type: COMPARATOR
Intervention: No hydrostatic pressure
Number of subjects: 30
Study: 8780073

Group type: EXPERIMENTAL
Intervention: Deprenyl
Number of subjects: 24
Study: 1740861

Group type: EXPERIMENTAL
Intervention: Educational memorandum outlining vaccine indications
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Personal letter mailed to a random sample of half of the remaining unimmunized persons
Number of subjects: 442

Group type: COMPARATOR
Intervention: No-letter controls
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Telephone call to half of the unimmunized letter recipients
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Vaccine offered directly in clinics and conferences
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Overall immunization rate at completion of the study
Number of subjects: 442
Study: 6430053

Group type: EXPERIMENTAL
Intervention: Low-dose NTG patches (n = 7)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Maximally tolerated NTG patches (first type, n = 8, mean NTG dose delivered 25 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Maximally tolerated NTG patches (second type, n = 5, mean NTG dose delivered 22 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sublingual NTG (positive control)
Number of subjects: 14
Study: 30371767

Group type: EXPERIMENTAL
Intervention: Immediate invasive strategy (STEMI-like)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Delayed invasive strategy (NSTEMI-like)
Number of subjects: 142
Study: 29470561

Group type: EXPERIMENTAL
Intervention: ePTFE-only group
Number of subjects: 129

Group type: COMPARATOR
Intervention: ePTFE with conchal cartilage group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129
Study: 27447428

Group type: EXPERIMENTAL
Intervention: VEL015 (sodium selenate) 10 mg tds (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (VEL015 320μg tds [n=10] or placebo [n=10])
Number of subjects: 40
Study: 24517114

Group type: EXPERIMENTAL
Intervention: Teduglutide 4 mg once daily for 10 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 23088906

Group type: EXPERIMENTAL
Intervention: CCBD (Continuous Controllable Balloon Dilator)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mechanical dilation (Hegar dilator)
Number of subjects: 120
Study: 20561625

Group type: EXPERIMENTAL
Intervention: 45 g whey protein isolate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 45 g sodium caseinate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 45 g glucose control
Number of subjects: 20
Study: 17318839

Group type: EXPERIMENTAL
Intervention: Sumanirole, 1 to 16 mg/day
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Ropinirole, 0.75 to 24 mg/day
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study: 15680855

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ringer lactate solution
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 16428575

Group type: EXPERIMENTAL
Intervention: LMA Unique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cobra PLA
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 80
Study: 10839469

Group type: EXPERIMENTAL
Intervention: Reboxetine 2-8 mg/day
Number of subjects: 12
Study: 8851895

Group type: EXPERIMENTAL
Intervention: Skirt group (wearing knee-length skirts)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trouser group (wearing full trousers)
Number of subjects: 12
Study: 1617494

Group type: EXPERIMENTAL
Intervention: Disodium monofluorophosphate-calcium carbonate (MFP-Ca) 100 mg with breakfast
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sodium fluoride (NaF) 25 mg fasting
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Disodium monofluorophosphate-calcium carbonate (MFP-Ca)
Number of subjects: 10
Study: 6393670

Group type: EXPERIMENTAL
Intervention: NPH biosynthetic human insulin
Number of subjects: 8

Group type: COMPARATOR
Intervention: NPH pork insulin
Number of subjects: 8
Study: 31834152

Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy for intermittent exotropia (60 minutes once per week for 12 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy for intermittent exotropia
Number of subjects: 14
Study: 30092952

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1869

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1869

Group type: EXPERIMENTAL
Intervention: Acute renal failure (ARF) after PCI
Number of subjects: 1869

Group type: COMPARATOR
Intervention: Acute renal failure (ARF) after CABG
Number of subjects: 1869

Group type: EXPERIMENTAL
Intervention: Primary composite endpoint (death, stroke, or MI) in patients with CKD
Number of subjects: 1869

Group type: COMPARATOR
Intervention: Primary composite endpoint (death, stroke, or MI) in patients without CKD
Number of subjects: 1869
Study: 26896263

Group type: EXPERIMENTAL
Intervention: PCI with Drug-Eluting Stents (DES)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Distal left main lesion with LVEF ≤45%
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High SYNTAX score
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Overall patients with Diabetes, LVEF ≤ 45%, and SYNTAX score >32
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: IC Stent, IVUS, or procedural strategy in distal lesion
Number of subjects: 86
Study: 24658221

Group type: EXPERIMENTAL
Intervention: Low dose ethanol (0.6 g/kg for females, 0.7 g/kg for males)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High dose ethanol (1.2 g/kg for females, 1.4 g/kg for males)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (alcohol-free drinks)
Number of subjects: 9
Study: 20974079

Group type: EXPERIMENTAL
Intervention: Psychoeducation by videotapes
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Psychoeducation plus telephone counseling
Number of subjects: 249

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 249
Study: 21442587

Group type: EXPERIMENTAL
Intervention: Eagle Tactical Athlete Program (ETAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory testing of musculoskeletal, biomechanical, physiological, and nutritional characteristics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injury surveillance
Number of subjects: 0
Study: 18618943

Group type: EXPERIMENTAL
Intervention: High-protein diet (30% carbohydrate, 40% protein, 30% fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet (55% carbohydrate, 15% protein, 30% fat)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 10
Study: 15740541

Group type: EXPERIMENTAL
Intervention: Tenatoprazole 40 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 24
Study: 11919405

Group type: EXPERIMENTAL
Intervention: Continuous intravenous sodium ferric gluconate (6.25-21.3 mg in every hemodialysis session)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intermittent sodium ferric gluconate (62.5 mg every 1-4 weeks)
Number of subjects: 26
Study: 10562740

Group type: EXPERIMENTAL
Intervention: Fundholding practices
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-fundholding practices
Number of subjects: 52
Study: 7717630

Group type: EXPERIMENTAL
Intervention: Nucleus 22 cochlear implant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smith & Nephew Richards Ineraid cochlear implant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3M/Vienna cochlear implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multichannel devices (Nucleus 22 and Ineraid)
Number of subjects: 0
Study: 31817080

Group type: EXPERIMENTAL
Intervention: DASH diet with caloric restriction of approximately 1673.6 kJ/day (400 kcal/day)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard hospital diet
Number of subjects: 67
Study: 27530332

Group type: EXPERIMENTAL
Intervention: 3 months training in Internet connectivity and social networking
Number of subjects: 76

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 76
Study: 27448761

Group type: EXPERIMENTAL
Intervention: Ficlatuzumab plus gefitinib
Number of subjects: 188

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 188
Study: 25372149

Group type: EXPERIMENTAL
Intervention: Traditional group-based HIV/STI prevention intervention (traditional WORTH)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Multimedia group-based HIV/STI prevention intervention (multimedia WORTH)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Wellness Promotion intervention (control condition)
Number of subjects: 306
Study: 23043926

Group type: EXPERIMENTAL
Intervention: Psychological intervention combined with Tagamet 800 mg per evening p.o.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Tagamet 800 mg per evening p.o.
Number of subjects: 96
Study: 19938712

Group type: EXPERIMENTAL
Intervention: 6% hydroxyexyethyl starch (HES) 200/0.5 ‐ Hemohes
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HES 130/0.4 ‐ Voluven
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Modified gelatin solution ‐ Gelofusin
Number of subjects: 36
Study: 17450977

Group type: EXPERIMENTAL
Intervention: 14-week course on Adapted Physical Education (APE)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study: 15204150

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 658

Group type: COMPARATOR
Intervention: Topical corticosteroids (TCS)
Number of subjects: 658
Study: 11588740

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (therapeutical and neuromuscular exercises with occupational therapy with professional supervision)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Home-based rehabilitation (conventional exercises with family caregiver and limited professional supervision)
Number of subjects: 60
Study: 9848512

Group type: EXPERIMENTAL
Intervention: Soy supplementation (60-g soy supplement containing 45 mg isoflavones) taken daily for 14 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal diet alone (Control)
Number of subjects: 48
Study: 8079970

Group type: EXPERIMENTAL
Intervention: Dialysate magnesium concentration of 0 mg/dL
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dialysate magnesium concentration of 0.6 mg/dL
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dialysate magnesium concentration of 1.8 mg/dL
Number of subjects: 8
Study: 2589846

Group type: EXPERIMENTAL
Intervention: Zidovudine syrup
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zidovudine solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zidovudine capsule
Number of subjects: 12
Study: 1039629

Group type: EXPERIMENTAL
Intervention: 50-minute class in acupuncture and Chinese medicine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre- and post-tests
Number of subjects: 80
Study: 31746078

Group type: EXPERIMENTAL
Intervention: HBsAg prevalence assessment
Number of subjects: 2715

Group type: EXPERIMENTAL
Intervention: HBV exposure assessment
Number of subjects: 2715

Group type: EXPERIMENTAL
Intervention: anti-HCV prevalence assessment
Number of subjects: 2715
Study: 31056306

Group type: EXPERIMENTAL
Intervention: AMH isoforms in women with PCOS
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: AMH isoforms in women with PCOS combined with androgens and BMI
Number of subjects: 112
Study: 28692467

Group type: EXPERIMENTAL
Intervention: Bolus-plus-infusion group (tranexamic acid 1g infusion for 8 hours)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Bolus group (placebo infusion for 8 hours)
Number of subjects: 168